Literature DB >> 22863622

Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer.

Hyun-A Kim1, Bon-Kyoung Koo, Ji-Hoon Cho, Yoon-Young Kim, Jinwoo Seong, Hee Jin Chang, Young Min Oh, Daniel E Stange, Jae-Gahb Park, Daehee Hwang, Young-Yun Kong.   

Abstract

Crosstalk between the Notch and wingless-type MMTV integration site (WNT) signaling pathways has been investigated for many developmental processes. However, this negative correlation between Notch and WNT/β-catenin signaling activity has been studied primarily in normal developmental and physiological processes in which negative feedback loops for both signaling pathways are intact. We found that Notch1 signaling retained the capability of suppressing the expression of WNT target genes in colorectal cancers even when β-catenin destruction by the adenomatous polyposis coli (APC) complex was disabled. Activation of Notch1 converted high-grade adenoma into low-grade adenoma in an Apcmin mouse colon cancer model and suppressed the expression of WNT target genes in human colorectal cancer cells through epigenetic modification recruiting histone methyltransferase SET domain bifurcated 1 (SETDB1). Extensive microarray analysis of human colorectal cancers also showed a negative correlation between the Notch1 target gene, Notch-regulated ankyrin repeat protein 1 (NRARP), and WNT target genes. Notch is known to be a strong promoter of tumor initiation, but here we uncovered an unexpected suppressive role of Notch1 on WNT/β-catenin target genes involved in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863622      PMCID: PMC3428081          DOI: 10.1172/JCI61216

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly.

Authors:  J Nakayama ; J C Rice; B D Strahl; C D Allis; S I Grewal
Journal:  Science       Date:  2001-03-15       Impact factor: 47.728

2.  Nrarp is a novel intracellular component of the Notch signaling pathway.

Authors:  E Lamar; G Deblandre; D Wettstein; V Gawantka; N Pollet; C Niehrs; C Kintner
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

3.  p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation.

Authors:  Vikram Devgan; Cristina Mammucari; Sarah E Millar; Cathrin Brisken; G Paolo Dotto
Journal:  Genes Dev       Date:  2005-06-15       Impact factor: 11.361

4.  Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2.

Authors:  Orbicia Riccio; Marielle E van Gijn; April C Bezdek; Luca Pellegrinet; Johan H van Es; Ursula Zimber-Strobl; Lothar J Strobl; Tasuku Honjo; Hans Clevers; Freddy Radtke
Journal:  EMBO Rep       Date:  2008-02-15       Impact factor: 8.807

5.  Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Authors:  Eek-hoon Jho; Tong Zhang; Claire Domon; Choun-Ki Joo; Jean-Noel Freund; Frank Costantini
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

6.  Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors.

Authors:  D Yan; M Wiesmann; M Rohan; V Chan; A B Jefferson; L Guo; D Sakamoto; R H Caothien; J H Fuller; C Reinhard; P D Garcia; F M Randazzo; J Escobedo; W J Fantl; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

7.  A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis.

Authors:  Andrew S Brack; Irina M Conboy; Michael J Conboy; Jeanne Shen; Thomas A Rando
Journal:  Cell Stem Cell       Date:  2008-01-10       Impact factor: 24.633

8.  Cdx1 promotes differentiation in a rat intestinal epithelial cell line.

Authors:  P Soubeyran; F André; J C Lissitzky; G V Mallo; V Moucadel; M Roccabianca; H Rechreche; J Marvaldi; I Dikic; J C Dagorn; J L Iovanna
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

9.  Glycogen synthase kinase-3beta modulates notch signaling and stability.

Authors:  Daniel R Foltz; Michelle C Santiago; Bridget E Berechid; Jeffrey S Nye
Journal:  Curr Biol       Date:  2002-06-25       Impact factor: 10.834

10.  Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis.

Authors:  Grégory Peignon; Aurélie Durand; Wulfran Cacheux; Olivier Ayrault; Benoît Terris; Pierre Laurent-Puig; Noah F Shroyer; Isabelle Van Seuningen; Tasuku Honjo; Christine Perret; Béatrice Romagnolo
Journal:  Gut       Date:  2011-02       Impact factor: 23.059

View more
  67 in total

Review 1.  Therapies targeting cancer stem cells: Current trends and future challenges.

Authors:  Denisa L Dragu; Laura G Necula; Coralia Bleotu; Carmen C Diaconu; Mihaela Chivu-Economescu
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

Review 2.  Wnt-Notch signalling crosstalk in development and disease.

Authors:  Giovanna M Collu; Ana Hidalgo-Sastre; Keith Brennan
Journal:  Cell Mol Life Sci       Date:  2014-06-19       Impact factor: 9.261

3.  Regulation of Monocarboxylic Acid Transporter 1 Trafficking by the Canonical Wnt/β-Catenin Pathway in Rat Brain Endothelial Cells Requires Cross-talk with Notch Signaling.

Authors:  Zejian Liu; Mary Sneve; Thomas A Haroldson; Jeffrey P Smith; Lester R Drewes
Journal:  J Biol Chem       Date:  2016-02-12       Impact factor: 5.157

Review 4.  Chemoprevention in gastrointestinal physiology and disease. Targeting the progression of cancer with natural products: a focus on gastrointestinal cancer.

Authors:  Roxane Khoogar; Byung-Chang Kim; Jay Morris; Michael J Wargovich
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-02-18       Impact factor: 4.052

5.  Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).

Authors:  Shivaani Kummar; Geraldine O'Sullivan Coyne; Khanh T Do; Baris Turkbey; Paul S Meltzer; Eric Polley; Peter L Choyke; Robert Meehan; Rasa Vilimas; Yvonne Horneffer; Lamin Juwara; Ann Lih; Amul Choudhary; Sandra A Mitchell; Lee J Helman; James H Doroshow; Alice P Chen
Journal:  J Clin Oncol       Date:  2017-03-28       Impact factor: 44.544

Review 6.  Desmoid-Type Fibromatosis: Who, When, and How to Treat.

Authors:  Javier Martínez Trufero; Isabel Pajares Bernad; Irene Torres Ramón; Jorge Hernando Cubero; Roberto Pazo Cid
Journal:  Curr Treat Options Oncol       Date:  2017-05

Review 7.  Colon cancer stem cells: controversies and perspectives.

Authors:  Maria Ausiliatrice Puglisi; Valentina Tesori; Wanda Lattanzi; Giovanni Battista Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

8.  Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice.

Authors:  Simone Ragusa; Borja Prat-Luri; Alejandra González-Loyola; Sina Nassiri; Mario Leonardo Squadrito; Alan Guichard; Sabrina Cavin; Nikolce Gjorevski; David Barras; Giancarlo Marra; Matthias P Lutolf; Jean Perentes; Emily Corse; Roberta Bianchi; Laureline Wetterwald; Jaeryung Kim; Guillermo Oliver; Mauro Delorenzi; Michele De Palma; Tatiana V Petrova
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

9.  Expression pattern of Notch intracellular domain (NICD) and Hes-1 in preneoplastic and neoplastic human oral squamous epithelium: their correlation with c-Myc, clinicopathological factors and prognosis in Oral cancer.

Authors:  Ravindran Gokulan; Devaraj Halagowder
Journal:  Med Oncol       Date:  2014-07-19       Impact factor: 3.064

10.  Notch-regulated ankyrin-repeat protein is a novel tissue biomarker that predicts poor prognosis in non-small cell lung cancer.

Authors:  Yufeng Liao; Junfeng Chen; Jianbo Ma; Qifeng Mao; Renxiong Wei; Jianjun Zheng
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.